Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Oncogene ; 33(13): 1640-8, 2014 Mar 27.
Article in English | MEDLINE | ID: mdl-23584481

ABSTRACT

LKB1/STK11 is a tumor suppressor gene responsible for Peutz-Jeghers syndrome, an inherited cancer disorder associated with genome instability. The LKB1 protein functions in the regulation of cell proliferation, polarization and differentiation. Here, we suggest a role of LKB1 in non-homologous end joining (NHEJ), a major DNA double-strand break (DSB) repair pathway. LKB1 localized to DNA ends upon the generation of micro-irradiation and I-SceI endonuclease-induced DSBs. LKB1 inactivation either by RNA interference or by kinase-dead mutation compromised NHEJ-mediated DNA repair by suppressing the accumulation of BRM, a catalytic subunit of the SWI/SNF complex, at DSB sites, which promotes the recruitment of an essential NHEJ factor, KU70. AMPK2, a major substrate of LKB1 and a histone H2B kinase, was recruited to DSBs in an LKB1-dependent manner. AMPK2 depletion and a mutation of H2B that disrupted the AMPK2 phoshorylation site impaired KU70 and BRM recruitment to DSB sites. LKB1 depletion induced the formation of chromosome breaks and radials. These results suggest that LKB1-AMPK signaling controls NHEJ and contributes to genome stability.


Subject(s)
AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/metabolism , DNA End-Joining Repair , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , AMP-Activated Protein Kinase Kinases , Cell Line, Tumor , Chromatin Assembly and Disassembly , Genes, Tumor Suppressor , Genomic Instability , Humans , Signal Transduction , Transfection
2.
Oncogene ; 30(18): 2135-46, 2011 May 05.
Article in English | MEDLINE | ID: mdl-21217779

ABSTRACT

Non-homologous end joining (NHEJ) is a major repair pathway for DNA double-strand breaks (DSBs) generated by ionizing radiation (IR) and anti-cancer drugs. Therefore, inhibiting the activity of proteins involved in this pathway is a promising way of sensitizing cancer cells to both radiotherapy and chemotherapy. In this study, we developed an assay for evaluating NHEJ activity against DSBs in chromosomal DNA in human cells to identify the chromatin modification/remodeling proteins involved in NHEJ. We showed that ablating the activity of the homologous histone acetyltransferases, CBP and p300, using inhibitors or small interfering RNAs-suppressed NHEJ. Ablation of CBP or p300 impaired IR-induced DSB repair and sensitized lung cancer cells to IR and the anti-cancer drug, etoposide, which induces DSBs that are repaired by NHEJ. The CBP/p300 proteins were recruited to sites of DSBs and their ablation suppressed acetylation of lysine 18 within histone H3, and lysines 5, 8, 12, and 16 within histone H4, at the DSB sites. This then suppressed the recruitment of KU70 and KU80, both key proteins for NHEJ, to the DSB sites. Ablation of CBP/p300 also impaired the recruitment of BRM, a catalytic subunit of the SWI/SNF complex involved in chromatin remodeling at DSB sites. These results indicate that CBP and p300 function as histone H3 and H4 acetyltransferases at DSB sites in NHEJ and facilitate chromatin relaxation. Therefore, inhibition CBP and p300 activity may sensitize cancer cells to radiotherapy and chemotherapy.


Subject(s)
Chromatin Assembly and Disassembly , Histones/metabolism , p300-CBP Transcription Factors/physiology , Acetylation , Catalysis , DNA Damage , Humans , Polymerase Chain Reaction
3.
Kyobu Geka ; 63(1): 23-7, 2010 Jan.
Article in Japanese | MEDLINE | ID: mdl-20077828

ABSTRACT

The surgical technique to achieve complete resection for superior sulcus tumor invading major anatomical sites including the subclavian vessels is challenging. The anterior transcervical-thoracic approach applied by Dartevelle and colleagues provides excellent exposure of the subclavian vessels. Grunenwald and associates have improved on this approach to preserve the clavicle and sternoclavicular joint. This paper describes the merits of this approach and details how to perform this surgical procedure.


Subject(s)
Lung Neoplasms/surgery , Pancoast Syndrome/surgery , Thoracic Surgical Procedures/methods , Humans , Neoplasm Invasiveness
4.
Mol Genet Genomics ; 265(5): 837-50, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11523801

ABSTRACT

The SGS1 gene of Saccharomyces (cerevisiae is a homologue of the genes affected in Bloom's syndrome, Werner's syndrome, and Rothmund-Thomson's syndrome. Disruption of the SGS1 gene is associated with high sensitivity to methyl methanesulfonate (MMS) and hydroxyurea (HU), and with hyper-recombination phenotypes, including interchromosomal recombination between heteroalleles. SGS1 encodes a protein which has a helicase domain similar to that of Escherichia coli RecQ. A comparison of amino acid sequences among helicases of the RecQ family reveals that Sgs1,WRN, and BLM share a conserved region adjacent to the C-terminal part of the helicase domain (C-terminal conserved region). In addition, Sgs1 contains two highly charged acidic regions in its N-terminal region and the HRDC (helicase and RNaseD C-terminal) domain at its C-terminal end. These regions were also found in BLM and WRN, and in Rqh1 from Schizosaccharomyces pombe. In this study, we demonstrate that the C-terminal conserved region, as well as the helicase motifs, of Sgs1 are essential for complementation of MMS sensitivity and suppression of hyper-recombination in sgs1 mutants. In contrast, the highly charged acidic regions, the HRDC domain, and the C-terminal 252 amino acids were dispensable for the complementation of these phenotypes. Surprisingly, the N-terminal 45 amino acids of Sgs1 were absolutely required for the suppression of the above phenotypes. Introduction of missense mutations into the region encoding amino acids 4-13 abolished the ability of Sgsl to complement MMS sensitivity and suppress hyper-recombination in sgs1 mutants, and also prevented its interaction with Top3, indicating that interaction with Top3 via the N-terminal region of Sgs1 is involved in the complementation of MMS sensitivity and the suppression of hyper-recombination.


Subject(s)
DNA Helicases/genetics , DNA Topoisomerases, Type I/genetics , Saccharomyces cerevisiae/genetics , Amino Acid Sequence , Antineoplastic Agents, Alkylating/pharmacology , Bloom Syndrome/genetics , Drug Resistance/genetics , Humans , Methyl Methanesulfonate/pharmacology , Molecular Sequence Data , RecQ Helicases , Recombination, Genetic , Rothmund-Thomson Syndrome/genetics , Saccharomyces cerevisiae Proteins , Sequence Alignment , Sequence Homology, Nucleic Acid , Werner Syndrome/genetics
5.
Genes Genet Syst ; 75(6): 319-26, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11280006

ABSTRACT

The SGS1 of Saccharomyces cerevisiae is a homologue for human Bloom's syndrome, Werner's syndrome, and Rothmund-Thomson's syndrome causative genes. Disruptants of SGS1 show high sensitivity to methyl methanesulfonate (MMS) and hydroxyurea, and hyper recombination phenotypes including interchromosomal homologous recombination in mitotic growth. In addition, sgs1 disruptants show poor sporulation and a reduced level of meiotic recombination as assayed by return-to-growth. We examined domains of Sgs1 required for mitotic and meiotic functions of Sgs1 by transfecting variously mutated SGS1 into sgs1 disruptants. The N-terminal 1-401 amino acid region was required for complementation of MMS sensitivity and suppression of hyper heteroallelic recombinations of sgs1 disruptants in mitotic growth and for complementation of poor sporulation and of reduced meiotic recombination. Although the N-terminal 1-125 amino acid region was absolutely required for the complementation of MMS sensitivity and suppression of hyper heteroallelic recombinations in mitotic growth, it was dispensable for the meiotic functions. In contrast, the highly acidic region (400-596 amino acid) was dispensable for the mitotic functions but a deletion of this region affected the meiotic functions. The C-terminal 1271-1350 amino acid region containing a HRDC (helicase and RNaseD C-terminal) domain was dispensable for the mitotic and meiotic functions. Although DNA helicase activity of Sgs1 was not required for Sgs1 to complement the meiotic functions, a deletion of helicase motifs III-IV (842-1046 amino acid) abolished the complementing activity of Sgs1, indicating that a structurally intact helicase domain is necessary for Sgs1 to fulfill its meiotic functions.


Subject(s)
DNA Helicases/metabolism , Homeodomain Proteins , Hydroxyurea/pharmacology , Meiosis , Methyl Methanesulfonate/pharmacology , Mitosis , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/growth & development , Sister Chromatid Exchange/genetics , Spores, Fungal/drug effects , Alleles , Cell Cycle Proteins/metabolism , Dose-Response Relationship, Drug , Fungal Proteins/metabolism , Gene Expression Regulation, Fungal , Genetic Complementation Test , Genotype , Mutagenesis, Site-Directed , Mutagens/pharmacology , Mutation, Missense , Phenotype , Plasmids/genetics , Recombination, Genetic/drug effects , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Sequence Homology, Amino Acid , Spores, Fungal/growth & development , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...